CytomX Therapeutics (CTMX)

CytomX Therapeutics (CTMX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• CTMX last traded at $2.34, 2.18% on the day.
• CytomX Therapeutics: market cap $509.88M, P/E -4.9, revenue $18.30M over the last four quarters, next earnings 2026-11-05.
• Over the past year CTMX returned -29.73%; year to date -45.07%.

Updated 2026-11-02 17:48 UTC